you are leaving Destracapital.com

It is important to note that by clicking on this link you will be leaving this website and any information viewed there is not the property of Destra Capital Investments LLC.

Strategies

Destra represents an array of investment products including Mutual Funds, Listed Closed-End Funds and Un-Listed Closed-End Funds. Destra Capital Investments, LLC serves as Distributor for all Destra Mutual Funds and Sub-Distributor for the Meridian Mutual Funds. Destra Capital Advisors LLC manages the Destra Mutual Funds and Un-Listed Closed-End Interval Funds and also acts as the secondary market servicing agent for all the Closed-End Funds listed below. Additional information on each product can be found by clicking the link on each respective product.

Important note: by clicking on a link to a non-Destra branded product, you will be leaving DestraCapital.com.


Quarterly

as of 9.30.20

fund name ticker 3 MO YTD 1YR 3YR 5YR from
incep.
distribution
Mutual Funds    
Destra Flaherty & Crumrine Preferred and Income
Inception Date: April 12, 2011
DPIAX A at NAV 5.36 -0.41 1.96 3.78 5.88 6.72 monthly
DPIAX A 0.62 -4.91 -2.62 2.20 4.91 6.20 monthly
DPIIX I 5.45 -0.23 2.22 4.03 6.17 7.04 monthly
DPICX C 4.14 -1.94 0.23 2.99 5.08 6.08 monthly
Destra Granahan Small Cap Advantage Fund
Inception Date: August 8, 2019
DGASX A at NAV 7.78 21.54 37.69 n/a n/a 23.63 annually
DGASX A 2.91 16.12 31.44 n/a n/a 18.77 annually
DGISX I 7.85 21.74 38.05 n/a n/a 23.80 annually
Destra International & Event-Driven Credit Fund
Inception Date: May 9, 2018
CEDAX A at NAV 5.85 -2.70 0.30 n/a n/a 6.46 quarterly
CEDAX A -0.24 -8.31 -5.47 n/a n/a 2.98 quarterly
CEDIX I 5.91 -2.56 0.51 n/a n/a 3.28 quarterly
CEDLX L 1.29 -7.01 -4.21 n/a n/a 3.63 quarterly
CEDTX T 2.54 -6.01 -3.23 n/a n/a 4.12 quarterly
Destra Multi-Alternative Fund
Inception Date: March 16, 2012
MSFDX at NAV 1.34 -10.14 -7.70 -2.93 0.39 2.66 monthly
MSFDX A -4.45 -15.31 -13.00 -4.82 -0.80 1.98 monthly
MSFIX I 1.43 -9.96 -7.46 -2.70 0.74 0.31 monthly
MCFDX C 1.15 -10.70 -8.37 -3.66 -0.36 -0.72 monthly
MSFYX T -1.86 -13.20 -10.98 -4.09 -0.87 -1.07 monthly
Meridian Growth
Inception Date: August 1, 1984
MRAGX A 8.94 0.59 9.57 7.82 12.13 9.26 annually
MRCGX C 8.75 0.08 8.83 7.06 11.36 8.17 annually
MRIGX Investor 9.05 0.83 9.94 8.13 12.46 9.61 annually
Meridian Contrarian
Inception Date: February 10, 1994
MFCAX A 7.82 -3.71 5.55 5.56 10.52 7.63 annually
MFCCX C 7.63 -4.25 4.81 4.88 9.85 6.80 annually
MFCIX Investor 7.91 -3.56 5.82 5.85 10.81 7.92 annually
Meridian Enhanced Equity
Inception Date: January 31, 2005
MRAEX A 10.42 15.03 22.21 21.86 19.20 13.99 annually
MRCEX C 10.30 14.73 21.70 21.36 18.71 15.85 annually
MRIEX Investor 10.52 15.08 22.49 22.13 19.48 14.25 annually
Meridian Small Cap Growth
Inception Date: December 15, 2013
MSGAX A 8.79 -0.64 12.00 7.02 11.85 10.98 annually
MSGCX C 8.60 -1.18 11.26 6.25 11.09 7.72 annually
MISGX Investor 8.89 -0.50 12.26 7.26 12.13 11.27 annually
Closed-End Funds    
Angel Oak Dynamic Financial Strategies Income Term Trust
Inception Date: June 26, 2020
DYFN Market -9.88 n/a n/a n/a n/a -8.28 monthly
XDFNX NAV 1.94 n/a n/a n/a n/a 1.94 monthly
Angel Oak Financial Strategies Income Term Trust
Inception Date: May 29, 2019
FINS Market 1.53 -14.04 -10.26 n/a n/a -5.94 monthly
XFINX NAV 2.76 -3.56 -1.61 n/a n/a 0.84 monthly
Ares Dynamic Credit Allocation Fund
Inception Date: November 27, 2012
ARDC Market 8.79 -11.00 -6.30 0.15 7.06 2.62 monthly
XADCX NAV 6.30 -7.03 -4.48 1.40 5.29 4.36 monthly
Flaherty & Crumrine Dynamic Preferred and Income
Inception Date: May 24, 2013
DFP Market 14.26 7.95 12.48 8.66 12.24 9.41 monthly
XDFPX NAV 8.14 -0.16 3.86 5.51 8.49 8.54 monthly
Flaherty & Crumrine Preferred Securities Income Fund
Inception Date: January 31, 2003
FFC Market 6.17 2.26 7.70 6.81 10.32 8.53 monthly
XFFCX NAV 7.46 -0.11 3.32 5.71 8.56 8.08 monthly
Flaherty & Crumrine Total Return Fund
Inception Date: August 29, 2003
FLC Market 9.92 1.62 2.71 7.43 10.88 8.13 monthly
XFLCX NAV 7.61 0.00 3.70 5.61 8.27 7.80 monthly
Tekla Healthcare Investors
Inception Date: March 8, 1992
HQH Market -1.06 5.53 22.55 2.07 3.41 0.00 quarterly
XHQHX NAV 0.57 8.10 27.66 5.49 4.56 11.02 quarterly
Tekla Life Sciences Investors
Inception Date: April 23, 1987
HQL Market 0.18 7.75 26.80 2.66 5.22 9.23 quarterly
XHQLX NAV -0.09 10.14 32.06 6.70 6.82 9.54 quarterly
Tekla Healthcare Opportunities Fund
Inception Date: July 28, 2014
THQ Market 3.51 0.49 11.80 7.03 10.80 6.37 monthly
XTHQX NAV 4.05 2.05 15.43 7.43 9.31 8.40 monthly
Tekla World Healthcare Fund
Inception Date: June 26, 2015
THW Market 2.74 12.04 18.47 10.57 10.72 3.72 monthly
XTHWX NAV 2.65 2.42 15.53 6.92 5.49 3.62 monthly

Monthly

as of 9.30.20

fund name ticker 3 MO YTD 1YR 3YR 5YR from
incep.
distribution
Mutual Funds    
Destra Flaherty & Crumrine Preferred and Income
Inception Date: April 12, 2011
DPIAX A at NAV 5.36 -0.41 1.96 3.78 5.88 6.72 monthly
DPIAX A 0.62 -4.91 -2.62 2.20 4.91 6.20 monthly
DPIIX I 5.45 -0.23 2.22 4.03 6.17 7.04 monthly
DPICX C 4.14 -1.94 0.23 2.99 5.08 6.08 monthly
Destra Granahan Small Cap Advantage Fund
Inception Date: August 8, 2019
DGASX A at NAV 7.78 21.54 37.69 n/a n/a 23.63 annually
DGASX A 2.91 16.12 31.44 n/a n/a 18.77 annually
DGISX I 7.85 21.74 38.05 n/a n/a 23.80 annually
Destra International & Event-Driven Credit Fund
Inception Date: May 9, 2018
CEDAX A at NAV 5.85 -2.70 0.30 n/a n/a 6.46 quarterly
CEDAX A -0.24 -8.31 -5.47 n/a n/a 2.98 quarterly
CEDIX I 5.91 -2.56 0.51 n/a n/a 3.28 quarterly
CEDLX L 1.29 -7.01 -4.21 n/a n/a 3.63 quarterly
CEDTX T 2.54 -6.01 -3.23 n/a n/a 4.12 quarterly
Destra Multi-Alternative Fund
Inception Date: March 16, 2012
MSFDX at NAV 1.34 -10.14 -7.70 -2.93 0.39 2.66 monthly
MSFDX A -4.45 -15.31 -13.00 -4.82 -0.80 1.98 monthly
MSFIX I 1.43 -9.96 -7.46 -2.70 0.74 0.31 monthly
MCFDX C 1.15 -10.70 -8.37 -3.66 -0.36 -0.72 monthly
MSFYX T -1.86 -13.20 -10.98 -4.09 -0.87 -1.07 monthly
Meridian Growth
Inception Date: August 1, 1984
MRAGX A 8.94 0.59 9.57 7.82 12.13 9.26 annually
MRCGX C 8.75 0.08 8.83 7.06 11.36 8.17 annually
MRIGX Investor 9.05 0.83 9.94 8.13 12.46 9.61 annually
Meridian Contrarian
Inception Date: February 10, 1994
MFCAX A 7.82 -3.71 5.55 5.56 10.52 7.63 annually
MFCCX C 7.63 -4.25 4.81 4.88 9.85 6.80 annually
MFCIX Investor 7.91 -3.56 5.82 5.85 10.81 7.92 annually
Meridian Enhanced Equity
Inception Date: January 31, 2005
MRAEX A 10.42 15.03 22.21 21.86 19.20 13.99 annually
MRCEX C 10.30 14.73 21.70 21.36 18.71 15.85 annually
MRIEX Investor 10.52 15.08 22.49 22.13 19.48 14.25 annually
Meridian Small Cap Growth
Inception Date: December 15, 2013
MSGAX A 8.79 -0.64 12.00 7.02 11.85 10.98 annually
MSGCX C 8.60 -1.18 11.26 6.25 11.09 7.72 annually
MISGX Investor 8.89 -0.50 12.26 7.26 12.13 11.27 annually
Closed-End Funds    
Angel Oak Dynamic Financial Strategies Income Term Trust
Inception Date: June 26, 2020
DYFN Market -9.88 n/a n/a n/a n/a -8.28 monthly
XDFNX NAV 1.94 n/a n/a n/a n/a 1.94 monthly
Angel Oak Financial Strategies Income Term Trust
Inception Date: May 29, 2019
FINS Market 1.53 -14.04 -10.26 n/a n/a -5.94 monthly
XFINX NAV 2.76 -3.56 -1.61 n/a n/a 0.84 monthly
Ares Dynamic Credit Allocation Fund
Inception Date: November 27, 2012
ARDC Market 8.79 -11.00 -6.30 0.15 7.06 2.62 monthly
XADCX NAV 6.30 -7.03 -4.48 1.40 5.29 4.36 monthly
Flaherty & Crumrine Dynamic Preferred and Income
Inception Date: May 24, 2013
DFP Market 14.26 7.95 12.48 8.66 12.24 9.41 monthly
XDFPX NAV 8.14 -0.16 3.86 5.51 8.49 8.54 monthly
Flaherty & Crumrine Preferred Securities Income Fund
Inception Date: January 31, 2003
FFC Market 6.17 2.26 7.70 6.81 10.32 8.53 monthly
XFFCX NAV 7.46 -0.11 3.32 5.71 8.56 8.08 monthly
Flaherty & Crumrine Total Return Fund
Inception Date: August 29, 2003
FLC Market 9.92 1.62 2.71 7.43 10.88 8.13 monthly
XFLCX NAV 7.61 0.00 3.70 5.61 8.27 7.80 monthly
Tekla Healthcare Investors
Inception Date: March 8, 1992
HQH Market -1.06 5.53 22.55 2.07 3.41 0.00 quarterly
XHQHX NAV 0.57 8.10 27.66 5.49 4.56 11.02 quarterly
Tekla Life Sciences Investors
Inception Date: April 23, 1987
HQL Market 0.18 7.75 26.80 2.66 5.22 9.23 quarterly
XHQLX NAV -0.09 10.14 32.06 6.70 6.82 9.54 quarterly
Tekla Healthcare Opportunities Fund
Inception Date: July 28, 2014
THQ Market 3.51 0.49 11.80 7.03 10.80 6.37 monthly
XTHQX NAV 4.05 2.05 15.43 7.43 9.31 8.40 monthly
Tekla World Healthcare Fund
Inception Date: June 26, 2015
THW Market 2.74 12.04 18.47 10.57 10.72 3.72 monthly
XTHWX NAV 2.65 2.42 15.53 6.92 5.49 3.62 monthly

Data presented reflects past performance, which is no guarantee of future results. Investment results and principal value will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Due to market volatility, current performance may be higher or lower than the performance shown.

*Due to the Fund's recent inception, performance data is not yet available.

Mutual Fund Related Risks

Performance shown for Class A Shares with load includes the Fund’s maximum sales charge of 4.50% for the Small Cap Advantage and the Flaherty & Crumrine Preferred and Income Funds. Returns include reinvestment of all distributions and returns of less than 1 year are not annualized.

For the Destra Flaherty & Crumrine Preferred and Income Fund, the Adviser has agreed to cap expenses such that the total annual fund operating expenses, excluding brokerage commissions and other trading expenses, taxes, interest, acquired fund fees and other extraordinary expenses (such as litigation and other expenses not incurred in the ordinary course of business) do not exceed 1.25%, 1.50% and 2.25% of the Fund’s average daily net assets attributable to Class I, Class A and Class C shares, respectively. The arrangement will continue in effect until January 28, 2029, may be terminated or modified prior to that date only with the approval of the Fund’s Board of Trustees and will automatically continue in effect for successive twelve-month periods thereafter. Class A and C shares have a 12b-1 fee of up to 0.25% and distribution fee of up to 0.75% for Class C Shares. A contingent deferred sales charge of 1.00% applies on Class C shares redeemed within 12 months of purchase.

For the Destra Granahan Small Cap Advantage Fund, the Adviser has agreed to cap expenses such that the total annual fund operating expenses, excluding brokerage commissions and other trading expenses, taxes, interest, acquired fund fees and other extraordinary expenses (such as litigation and other expenses not incurred in the ordinary course of business), do not exceed 1.75%, and 1.50% of the Fund’s average daily net assets attributable to Class A Shares and Class I Shares, respectively. The arrangement will continue in effect until January 28, 2029, may be terminated or modified prior to that date only with the approval of the Fund’s Board of Trustees (“Board”) and will automatically continue in effect for successive twelve-month periods thereafter. Any fee waived and/or expense assumed by the Adviser pursuant to the arrangement is subject to recovery by the Adviser for up to three years from the date the fee was waived and/or expense assumed, but no reimbursement payment will be made by the Fund if such reimbursement results in the Fund exceeding an expense ratio equal to the Fund’s then-current expense caps or the expense caps that were in place at the time the fee was waived and/or expense assumed by the Adviser. Class A Shares include a shareholder servicing fee and/or distribution fee of up to 0.25%.

Destra and the International & Event-Driven Credit Fund have entered into the Expense Limitation Agreement under which Destra has agreed to reimburse and/or pay or absorb, on a quarterly basis, the “ordinary operating expenses” (as defined below) of the Fund to the extent that such expenses exceed 0.50% per annum of the Fund’s average daily net assets (the “Expense Limitation”). The Expense Limitation may be adjusted for different classes of Shares to account for class-specific expenses. In consideration of Destra’s agreement to limit the Fund’s expenses, the Fund has agreed to repay Destra pro rata in the amount of any Fund expense paid or waived by it, subject to the limitations that: (1) the reimbursement for expenses will be made only if payable not more than three years following the time such payment or waiver was made; and (2) the reimbursement may not be made if it would cause the Fund’s then-current Expense Limitation, if any, and the Expense Limitation that was in effect at the time when Destra reimbursed, paid or absorbed the ordinary operating expenses that are the subject of the repayment, to be exceeded. Unless earlier terminated by the Board, the Expense Limitation Agreement will remain in effect until February 13, 2029, and will automatically continue in effect for successive twelve-month periods thereafter. Destra may not terminate the Expense Limitation Agreement during the initial term. After the initial term, either the Board or Destra may terminate the Expense Limitation Agreement upon 30 days’ written notice. Class A, L and T shares have a shareholder servicing fee of up to 0.25% and distribution fee of 0.25% for Class L and 0.50% for Class T Shares.

The Fund’s Adviser has contractually agreed to reduce its fees and/or absorb expenses of the Destra Multi Alternative Fund, until at least November 30, 2020, to ensure that total annual fund operating expenses after fee waiver and/or reimbursement (excluding any front-end or contingent deferred loads, brokerage fees and commissions, acquired fund fees and expenses, fees and expenses associated with instruments in other collective investment vehicles or derivative instruments (including for example options and swap fees and expenses), borrowing costs (such as interest and dividend expense on securities sold short), taxes and extraordinary expenses, such as litigation expenses (which may include indemnification of Fund officers and Trustees and contractual indemnification of Fund service providers (other than the Adviser)) will not exceed 1.70% for Class I Shares, 1.95% for Class A Shares, 2.70% for Class C Shares, and 2.45% for Class T Shares, and of each class’s net assets, respectively. Expense waivers and reimbursements are subject to possible recoupment from the Fund in future years on a rolling three year basis (within the three years after the fees have been waived or reimbursed) if such recoupment can be achieved within the lesser of the foregoing expense limits or those in place at the time of recapture. This agreement may be terminated only by the Fund’s Board of Trustees, on 60 days written notice to the Adviser. Class C and T shares have a distribution fee of up to 0.50% and 0.75%, respectively.

Included in the each Fund’s Class A shares expenses is a distribution and service (12b-1) fee of 0.25%.

Included in the each Fund’s Class C shares expenses is a distribution and service (12b-1) fee of 1.00%.

Investing outside the United States involves additional risks, such as currency fluctuations, political instability risks, periods of illiquidity, and price volatility, as more fully described in the prospectus. These risks may be heightened in connection with investments in developing countries. Small company stocks entail additional risks, and they can fluctuate in price more than larger company stocks. The value of fixed-income securities may be affected by changing interest rates and changes in credit ratings of the securities. As interest rates rise, the prices of fixed-income securities generally fall. Lower rated bonds and preferred securities are subject to greater fluctuations in value and risk of loss of income and principal than higher rated bonds. For more information about the risks associated with each fund, go to its detailed fund information page or read the prospectus.

Some important risks of the Preferred and Income Fund are: market risk, preferred and subordinated security risk, credit risk, interest rate risk, high-yield securities risk, liquidity risk, non-u.s. investment risk, non-diversification risk, securities selection risk, investment risk and issuer concentration in industries with regulated capital structure.

Some important risks of the Granahan Small Cap Advantage Fund are: investment strategy risk, equity securities risk, market risk, growth securities risk and small company risk.

Closed-End Fund Related Risks

Performance data quoted represents past performance, which is no guarantee of future results, and current performance may be lower or higher than the figures shown. The NAV total return takes into account the Fund’s total annual expenses and does not reflect transaction charges. All distributions are assumed to be reinvested either in accordance with the dividend reinvestment plan (DRIP) for market price returns or NAV for NAV returns. Until the DRIP price is available from the Plan Agent, the market price returns reflect the reinvestment at the closing market price on the last business day of the month. Once the DRIP is available around mid-month, the market price returns are updated to reflect reinvestment at the DRIP price.

This information does not represent an offer to sell securities of the Funds nor is it soliciting an offer to buy securities of the Funds. There can be no assurance that the Funds will achieve their investment objectives. The value of the Funds will fluctuate with the value of the underlying securities. Historically, closed-end funds often trade at a discount to their net asset value. Both the net asset value and the market value of shares of common stock may be subject to high volatility and a decline in value.

Destra Capital Advisors LLC is providing secondary market servicing for the the Angel Oak Financial Strategies Income Term Trust, Angel Oak Dynamic Financial Strategies Income Term Trust, Ares Dynamic Credit Allocation Fund, the Flaherty & Crumrine Dynamic Preferred and Income Fund, the Flaherty & Crumrine Preferred Securities Income Fund, the Flaherty & Crumrine Total Return Fund, the Tekla Healthcare Investors Fund, the Tekla Life Sciences Investors Fund, the Tekla Healthcare Opportunities Fund, the Tekla World Healthcare Fund.

Investing in the market is subject to risk and possible loss of principal amount invested.

Data provided by Destra Capital Investments unless otherwise noted.

Investors should consider the investment objective and policies, risk considerations, charges and ongoing expenses of an investment carefully before investing. The prospectus and summary prospectus contains this and other information relevant to an investment in the fund. Please read the prospectus or summary prospectus carefully before you invest or send money. To obtain a prospectus, please contact your investment representative or Destra Capital Investments LLC at 877.287.9646 or access our literature page.